IJPRS

Home Abstract

Development and Validation of a RP-HPLC Method for the Simultaneous Estimation of Ranitidine Hydrochloride and Dicyclomine Hydrochloride in Tablet Dosage Forms


Received On: 22/06/2013
Accepted On: 03/07/2013


Author(s)

Kantariya, B., Agola, A., Roshani, H., Ghetia, U., Shivam, S. S.


Author's Affiliation


Abstract

An accurate, precise and reproducible high performance liquid chromatographic method was developed for simultaneous estimation of Ranitidine Hydrochloride and Dicyclomine Hydrochloride in tablet dosage forms. Chromatographic separation of the drugs were achieved on a Phenomenax C18 column (150 x 4.6 mm; 5μ) using a mobile phase consisting of ortho-Phosphoric acid 0.1% and Acetonitrile pH 3.5 (25:75, %v/v) at a flow rate of 0.5 ml/min. The drugs elute were monitored at 218 nm. The retention time obtained for the Ranitidine Hydrochloride was 4.32 min and for the Dicyclomine Hydrochloride was 5.96 min. The calibration curves were linear over the range of 5-25 μg/ml and 50-250 μg/ml for Ranitidine Hydrochloride and Dicyclomine Hydrochloride respectively. The performance of the method was validated according to ICH guidelines. The method could be applied for determination of in its tablet dosage forms without any interference from excipients or endogenous substances. The proposed method is suitable for routine quality control analysis.


Keywords

High Performance liquid Chromatography, Ranitidine Hydrochloride (RANTD), Dicyclomine Hydrochloride (DICY)

Cite This Article

Kantariya, B., Agola, A., Roshani, H., Ghetia, U., & Shivam, S. S. (2013). Development and Validation of a RP-HPLC Method for the Simultaneous Estimation of Ranitidine Hydrochloride and Dicyclomine Hydrochloride in Tablet Dosage Forms. International Journal for Pharmaceutical Research Scholars (IJPRS), 2(2), 258-267.


Recent Articles

Get FREE Updates for Upcoming
Pharma News, Jobs & Conferences

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

IJPRS will use the information you provide on this form to be in touch with you and to provide updates and marketing.